C.L. van der Wilt

3.2k total citations
60 papers, 2.7k citations indexed

About

C.L. van der Wilt is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C.L. van der Wilt has authored 60 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 26 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C.L. van der Wilt's work include Colorectal Cancer Treatments and Studies (39 papers), Gastric Cancer Management and Outcomes (15 papers) and Biochemical and Molecular Research (14 papers). C.L. van der Wilt is often cited by papers focused on Colorectal Cancer Treatments and Studies (39 papers), Gastric Cancer Management and Outcomes (15 papers) and Biochemical and Molecular Research (14 papers). C.L. van der Wilt collaborates with scholars based in Netherlands, United States and Italy. C.L. van der Wilt's co-authors include Godefridus J. Peters, Herbert M. Pinedo, Kees Smid, C.J. van Groeningen, Sybren L. Meijer, Paul Noordhuis, Baukelien van Triest, Judith R. Kroep, Andries M. Bergman and Giovanni Codacci-Pisanelli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

C.L. van der Wilt

60 papers receiving 2.6k citations

Peers

Countries citing papers authored by C.L. van der Wilt

Since Specialization

Citations

This map shows the geographic impact of C.L. van der Wilt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L. van der Wilt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L. van der Wilt more than expected).

Fields of papers citing papers by C.L. van der Wilt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.L. van der Wilt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L. van der Wilt. The network helps show where C.L. van der Wilt may publish in the future.

Co-authorship network of co-authors of C.L. van der Wilt

This figure shows the co-authorship network connecting the top 25 collaborators of C.L. van der Wilt. A scholar is included among the top collaborators of C.L. van der Wilt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.L. van der Wilt. C.L. van der Wilt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence Advancements in Cardiomyopathies: Implications for Diagnosis and Management of Arrhythmogenic Cardiomyopathy 2024 ·Current Heart Failure Reports ·(unknown), C.L. van der Wilt, Martina Calore, René van Es, Alessandra Rampazzo, Pim van der Harst, Frank G. van Steenbeek, J. Peter van Tintelen, Magdaléna Harakaľová, Anneline S.J.M. te Riele	3
2	Selective Protection by Uridine of Growth Inhibition by 5-Fluorouracil (5FU) Mediated by 5FU Incorporation into RNA, But Not the Thymidylate Synthase Mediated Growth Inhibition by 5FU-Leucovorin 2008 ·Nucleosides Nucleotides & Nucleic Acids ·Giovanni Codacci-Pisanelli, Paul Noordhuis, C.L. van der Wilt, Godefridus J. Peters	7
3	First results of triple‐modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with Stage IIB, III, and IVA cervical carcinoma 2005 ·Cancer ·Anneke M. Westermann, Ellen L. Jones, Baard‐Christian Schem, Elzbieta M. van der Steen‐Banasik, P. Koper, Olav Mella, A. L. J. Uitterhoeve, Ronald de Wit, Jacobus van der Velden, Curt W. Burger, C.L. van der Wilt, Olav Dahl, Leonard R. Prosnitz, Jacoba van der Zee	91
4	A Non‐Radioactive Sensitive Assay to Measure 5‐Fluorouracil Incorporation into DNA of Solid Tumors 2004 ·Nucleosides Nucleotides & Nucleic Acids ·Paul Noordhuis, U. Holwerda, Jan van Laar, C.L. van der Wilt, Godefridus J. Peters	6
5	5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers 2004 ·Annals of Oncology ·Paul Noordhuis, U. Holwerda, C.L. van der Wilt, C.J. van Groeningen, Kees Smid, Sybren L. Meijer, Herbert M. Pinedo, Godefridus J. Peters	210
6	Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2′-2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 2004 ·Biochemical Pharmacology ·Ashraf Al Madhoun, C.L. van der Wilt, Willem J.P Loves, José M. Padrón, Staffan Eriksson, Iannis Talianidis, Godefridus J. Peters	17
7	Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver 2003 ·European Journal of Cancer ·C.L. van der Wilt, Judith R. Kroep, Willem J.P Loves, Marianne G. Rots, C.J. van Groeningen, Gertjan J.L. Kaspers, Godefridus J. Peters	42
8	Thymidylate Synthase Inhibition Induces P53 Dependent and Independent Cell Death 2002 ·Advances in experimental medicine and biology ·Harold H.J. Backus, D. Wouters, C.L. van der Wilt, (unknown), Cees J. van Groeningen, (unknown), (unknown), Godefridus J. Peters	5
9	The Role of Deoxycytidine Kinase in Gemcitabine Cytotoxicity 2002 ·Advances in experimental medicine and biology ·C.L. van der Wilt, Judith R. Kroep, Andries M. Bergman, Willem J.P Loves, Enrique Álvarez, Iannis Talianidis, Staffan Eriksson, Cees J. van Groeningen, Herbert M. Pinedo, Godefridus J. Peters	25
10	Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism 2002 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Godefridus J. Peters, Harold H.J. Backus, (unknown), Baukelien van Triest, Giovanni Codacci-Pisanelli, C.L. van der Wilt, Kees Smid, John Lunec, A. Hilary Calvert, Sharon Marsh, Howard L. McLeod, Elisabeth Bloemena, Sybren L. Meijer, Gerrit Jansen, C.J. van Groeningen, Herbert M. Pinedo	328
11	Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. 2001 ·Data Archiving and Networked Services (DANS) ·C.L. van der Wilt, Harold H.J. Backus, Kees Smid, (unknown), G. Veerman, D. Wouters, Daphne Voorn, David G. Priest, Marlene A. Bunni, F. Mitchell, Ann L. Jackman, Gerrit Jansen, Godefridus J. Peters	56
12	FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects 2001 ·Transplantation Proceedings ·Volker Brinkmann, C.L. van der Wilt, Colette Kristofic, Zariana Nikolova, Robert P. Hof, (unknown), Rainer Albert, Sylvain Cottens	39
13	Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed 2000 ·European Journal of Cancer ·Godefridus J. Peters, Baukelien van Triest, Harold H.J. Backus, C.M. Kuiper, C.L. van der Wilt, Herbert M. Pinedo	77
14	5-Ethyl-2′-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil 1999 ·Journal of Cancer Research and Clinical Oncology ·Judit Kralovánszky, (unknown), András Jeney, (unknown), Paul Noordhuis, (unknown), László Ötvös, Péter Kovács, C.L. van der Wilt, Godefridus J. Peters	7
15	The Role of Thymidine Kinase Activity in Murine Colon Tumours Treated with 5-Fluorouracil 1998 ·Advances in experimental medicine and biology ·C.L. van der Wilt, Kees Smid, G. Veerman, Godefridus J. Peters	5
16	Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression 1997 ·Biochemical Pharmacology ·Baukelien van Triest, Herbert M. Pinedo, (unknown), C.L. van der Wilt, Gerrit Jansen, Godefridus J. Peters	28
17	Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice 1995 ·European Journal of Cancer ·Giovanni Codacci-Pisanelli, C.L. van der Wilt, Herbert M. Pinedo, Fabrizió Franchi, Paul Noordhuis, Boudewijn J.M. Braakhuis, Jan van Laar, Godefridus J. Peters	19
18	The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the rat 1995 ·European Journal of Cancer ·C.L. van der Wilt, Andreas Marinelli, Herbert M. Pinedo, Jacqueline Cloos, Kees Smid, C.J.H. Van de Velde, Godefridus J. Peters	16
19	Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase 1994 ·European Journal of Cancer ·Godefridus J. Peters, C.L. van der Wilt, C.J. van Groeningen	27
20	In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis 1993 ·British Journal of Cancer ·C.L. van der Wilt, Gerard W.M. Visser, (unknown), (unknown), Paul Noordhuis, Kees Smid, Godefridus J. Peters	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact